A B S T R A C T The role of immune cell products in modulating connective tissue metabolism was investigated. Supernates of both unstimulated and phytohemagglutinin-stimulated human mononuclear cell cultures suppressed fibroblast proliferation (up to 90%) and concomitantly stimulated fibroblast prostaglandin E (PGE) synthesis (20-to 70-fold). The growth suppression was, at least in part, a secondary result of the increased fibroblast PGE synthesis; growth suppression (a) paralleled the increased fibroblast PGE synthesis, (b) was reversed by addition of inhibitors of prostaglandin synthesis (indomethacin, meclofenamate, and eicosatetraynoic acid), and (c) was reproduced by addition of exogenous PGE2 to fibroblast cultures. The prostaglandin-stimulatory, growth-suppressive activity was a product of non-T-lymphocyte, adherent cells and was present within 6 h ofmononuclear cell culture. The activity was heat (560C) and trypsin sensitive, nondialyzable, and appeared in the 12,000-20,000 mol wt fractions on Sephadex G-100 chromatography. The activity in supemates of mononuclear cell cultures was removed by incubation with fibroblasts but not by similar incubation with peripheral blood mononuclear cells. Mononuclear cells release a factor(s) which modulates fibroblast proliferation by altering prostaglandin metabolism. INTRODUCTION Inflammatory lesions are characterized by the participation and interaction of several different cell types. One
example is the cooperation of lymphocytes and monocytes in immune responses, an interaction mediated in part by release of soluble factors (lymphokines and monokines) which affect cell metabolism. The relationship between these mononuclear cells and other cell types involved in complex inflammatory states is less well defined.
The involvement of connective tissue elements in lesions such as granulomas, neoplasms, healing wounds, and vasculitis has generated interest in the modulation of connective tissue metabolism by immunologically active cell populations (1) (2) (3) (4) (5) (6) . Experimental evidence indicates that factors released by mononuclear cells (lymphocytes and monocytes) may affect fibroblast chemotaxis (1), stimulate fibroblast proliferation (2) , and enhance collagen and proteoglyean synthesis (3, 4) . The interaction between fibroblasts and mononuclear cells may be bidirectional; under certain conditions fibroblasts may produce migration inhibitory factor (7) and substitute for adherent cells in the immune response (8) . Furthermore, connective tissue cell products, such as prostaglandins, may plav a role in modulating immune function (9) .
In the present studies, we investigated the ability of mononuclear cells to influence fibroblast proliferation. Supernates of human mononuclear cell cultures suppressed the proliferation of dermal fibroblasts in vitro. This suppression was mediated, at least in part, by stimulation of fibroblast prostaglandin synthesis.
South Carolina. The cells had the typical spindle-shaped appearance of FB and synthesized collagen as 2-4% of cell protein. Cells were maintained in basal Eagle's mediutm (Grandl Island Biological Co., Grand Island, N. Y.) supplemented with 10% heat-inactivated fetal bovine serum (Grand Islandl Biological Co.), 25 mnM Hepes buffer, L-glutamine (2 mnM), penicillin (100 U/ml), and streptomvcin (100 gg/miil). Cells were fed twice weeklv, transferred at confluence, and used for experiments betweeni the 8th ancd 30th subpassage in culture.
Stupertiatatt preparationi. Nonmlal humani peripheral blood mononuclear cells (PBMC) Nere isolated by flotation on Lvimphocvte Separation Media (Litton Bionetics, Kensinigton, Md.) and( washed three times in Hanks' balanced salt solutioni. For prodluctioni of superniates (SN), cells (5 x 105/ ml) vere cultured for 72 h at 37°C in a 5% CO2-humidified atmiiosphere in RPMI-1640 (GranJf Islandl Biological Co.) supplemiienitedl with 20% heat-inactivated humllani AB serumil, 25 mM Hepes buffer, 2 mnM glutamiinie, penicillini, andl strep- tomvcin in 75-mmlll polypropylene tubes (Falconi Labware, Oxnardl, Calif.) with or without phytohemagglutinin (Burroughs WVellcome, Research Triangle Park, N. C.), 2.5,ig/ml, the p)reviously determiniedl optimal mitogeniic dose. To terminate cultures, tubes were cenitrif'uged at 400 g f'or 10 min, ancd the SN imediun wvas aspiratedc andI passedl through a 0.45-gum filter (Millipore, Corp., Bedford, Mass.). Cell-free SN were storecl at -200C and diluted in RPMI-1640 with 20%
heat-inactivated AB serumll before use (usually within 2 wk).
In somiie experimenits, PBMC were fractioniated before culture for SN (11) . The PGE fractioni was converted to PGB using 0.1 N KOH/methanol (12) , and assayed usinlg a previously describedl radioimimunoassay procedure (12) . The antibody used cross-reacts with both prostaglandins E, andl E2 andcl therefore the term iPGE is used; the antibody dloes nlot cross-react significantly svith the other major pareint prostaglanidinis (11 (Fig. 1) . SN ofPHA-stimulated cultures had greater suppressive activity than those of unstimulated cultures (P < 0.01 by Student's t test at all concentrations shown) although for some preparations the difference was apparent only at low SN coincentrations. PHA alone, at concentrations of 0.02-2.5 ,ug/ml, had no effect on thvmidine incorporation by FB (range 0-3, mean 1±2% [SEMNi suppression).
Although suppression of cell number by SN preparations was usually evident bv microscopic examination of the microtiter wells before harvesting, parallel experiments using direct cell counts were performed to insure that thymidine incorporation was a true reflection of cell proliferation. A suppression of cell number at the end of 48 h was evident in cultures containing either unstimulated or PHA-stimulated PBMIC-SN (Table I) . PHA alone (at a concentration equivalent to that present in the 25% PBMIC-SN preparation, asstiminig Ino PHA had been consumed during the original PBMIC culture) had no significant effect on cell number. Parallel experiments comparing [3H]thvmidine incorporation and direct cell counts showed a strong positive correlation (in = 12, r = 0.89, P < 0.01 by Student's t test).
The suppression of proliferation seen was not due to exhauistion of nutrients or lower effective serum concentration in the added SN. Addition of either 25% Stimulation of prostaglandin synthesis in FB by PBAIC-SN. FB grown in the presence of PBMC-SN showed a marked increase in the production of iPGE (Table II) . Untreated FB cultures release little iPGE into the media. The addition of SN, either unstimulated or PHA-stimulated, resulted in a 50-to 70-fold increase in iPGE synthesis. Addition of PHA alone resulted in only a slight increase in iPGE production. The increase in iPGE in the cultures to which SN had been added could not be explained by passive transfer of iPGE from the mononuclear cell cultures since iPGE concentrations in SN preparations were only severalfold greater than that of media alone (3.3-4.7 vs. 0.7 ng/ml).
Relationship between prostaglandin synthesis and grotwth suppression. The increase in iPGE synthesis was dose dependent and paralleled the growth-suppressive effect at different PBMC-SN concentrations (Fig. 2 ). Both growth suppression and stimulation of prostaglandin svnthesis were detectable within 6 h (Table IV) . Addition of 5-500 ng of PGE2/ml of culture medium at the initiation of the culture had no significant effect on FB proliferation. Addition of 5,000 ng/ml resulted in a growth-suppressive effect similar to that seen with PBMC-SN. Because much lower concentrations of PGE were associated with growth suppression in PBMC-SN-treated cultures and because prostaglandins might be labile or rapidly metabolized, lower concentrations of PGE2 were added at multiple time points Fig. 2 ) at 0, 24, and 40 h of culture suppressed FB thymidine incorporation by 48% whereas a 10-fold higher concentration (500 ng/ml) added only at the beginning ofthe culture had no growth-suppressive effect (Table IV) . The addition of exogenous PGE2 was also able to reverse the inhibitory effect ofindomethacin on PBMC-SN-induced growth suppression (Table IV) . PBMC-SN thus suppressed thymidine incorporation by FB cultures, and this effect was reversed, in part, by the prior addition of indomethacin; addition of exogenous PGE2 restored the growth suppression similar to that seen without indomethacin.
Production of grow,th-suppressive activity. To determine the cell of origin of the growth-suppressive and prostaglandin-stimulatory activities, PBMC were fractionated by depletion or enrichment of E-RFC (T lymphocytes) on a Ficoll-Hypaque gradient, and the resultant cell populations cultured for 72 h with PHA. SN of unfractionated PBMC and of PBMC depleted of E-RFC showed similar growth-suppressive activity (Table V) . SN of E-RFC-enriched cultures caused little growth suppression. Media of FB cultures exposed to SN of unfractionated, E-RFC-enriched, and E-RFCdepleted PBMC cultures were assayed for iPGE. iPGE stimulatory activity was present in SN of both unfractionated and E-RFC-depleted cultures. SN of E-RFCenriched PBMC gave almost no stimulation of iPGE synthesis (Table V) . Similar experiments were donie using PBMC depleted of adherent cells. SN of nonadherent PBMC did not suppress FB growth and did not stimulate iPGE syn.hesis (Table V) consistent with the lack of activity of nonadherent cells which would contain almost all the contaminating platelets. Growth-suppressive activity appeared in the SN of PHA-stimulated PBMC cultures within 2 h (Table VI) . The growth-suppressive activity in SN of 2-h cultures was present only at the highest concentration tested and was completely reversed by indomethacin. The growth-suppressive activity in SN of 6-, 24-, and 72-h cultures was evident at lower SN concentrations (i.e., present at higher titer); at higher SN concentrations, it was only partly reversed by prior addition of indomethacin. PGE-dependent, indomethacin-reversible growthsuppressive activity thus appears earlier in the SN of PBMC cultures and is present in higher titer than the prostaglandin-independent growth-suppressive activity.
Physical characteristics ofPBMC-SN activity. The growth-suppressive activity in PBMC-SN was partially destroyed by heating at 560C for 1 h and completely destroyed by similar incubation at 800C (not shown).
Incubation at 560C resulted in a reduction of both indomethacin-reversible and indomethacin-irreversible 4 Final indomethacin concentration, 1.0,ug/ml. growth suppression, both of which could be detected only at high SN concentrations. PBMC-SN and control media (RPMI/20% AB) were treated with trypsin and soybean trypsin inhibitor or with PBS and tested for effect on FB proliferation (Table VII) . Control media treated with trypsin-trypsininhibitor suppressed FB thymidine incorporation slightly when compared with PBS-treated media. The growthsuppressive activity of PBMC-SN was almost completely abolished by trypsin treatment; residual growth suppression approximated that seen with trypsin-trypsin inhibitor-treated control media and was not reversed by indomethacin (Table VII) .
PBMC-SN was fractionated by molecular sieve chromatography on G-100 Sephadex (Pharmacia Fine Chemicals, Div. Pharmacia Inc., Piscataway, N. J.). Column fractions were pooled (Fig. 6A) 24 1 ml of SN was incubated for 1 h at 370C with 0.5 ml of 1% trypsin (T) (type III, Sigma Chemical Co.) in PBS; 0.5 ml of 1% soybean trypsin inhibitor (STI) (type I-S, Sigma Chemical Co.) in PBS was then added for 10 min. Controls consisted of RPMI 1640/20% AB serum similarly treated and SN incubated similarly with PBS. All dilutions were made in 50% RPMI-AB serum/50% PBS. Final concentration of serum in all wells was 15% and of PBS, 25%.
[3H]TdR incorporation (percentage suppression) is compared with FB cultured in RPMI/15% AB serum/25% PBS. Each value is the mean of quadruplicate cultures.
* Final indomethacin concentration 1.0 ,g/ml.
4 P < 0.01 for comparisons shown (Student's t test).
for their effect on FB iPGE synthesis (Fig. 6C) . FB iPGE synthesis in untreated control inedium was 1.2+0.1 nglml. There was a 40-to 50-fold stimulation of iPGE synthesis by PBMC-SN which was unaffected by dialysis of the SN. In chromatographed SN, prostaglandinstimulatory activity was present largely in fraction III and to a lesser extent in fraction I, the same fractions Absorption of PBMC-SN activity. PBMIC-SN was incubated with FB to determine whether the growthsuppressive, prostaglandin-stimulatory activity could be removed. PBMC and trypsin-treated PBMC were used as absorption controls, the latter because (Table VIII) . PHA-stimulated PBMC-SN was then tested for effect on thymidine incorporation by fresh PHA-stimulated lymphocyte cultures (Table IX) (18) indicating that the activity is, indeed, mononuclear cell derived.
A number of factors have been identified in SN of mononuclear cell cultures which may suppress cell proliferation. Lymphotoxin, a T-lymphocyte product, suppresses cell proliferation by a cytotoxic effect (13) . Proliferation inhibitory factor can be detected in SN of unstimulated mononuclear cells and suppresses growth of a variety of target cells (14) ; proliferation inhibitory factor may be identical to lymphotoxin, a noncytotoxic but growth-suppressive activity resulting at low concentrations of proliferation inhibitory factor-lymphotoxin (19, 20) . Inhibitor of DNA synthesis, an 80,000 mol wt glycoprotein product of rat lymphocytes, can suppress proliferation of FB as well as of mitogenstimulated lymphocytes (14) . The mechanism of inhibitor of DNA synthesis action appears to be stimulation of cAMP in the target cell (21, 22) . Since PGE can stimulate cAMP synthesis, the factor(s) responsible for the indomethacin-reversible growth suppression observed in the present report might be related to inhibitor of DNA synthesis. Unlike inhibitor of DNA synthesis, our PBMC-SN does not suppress PHA-induced lymphocyte proliferation, does not appear to be produced by T lymphocytes, and is of considerably lower molecular weight.
The high level of PGE2 synthesis by PBMC-SNstimulated FB (-10 ng/104 cells in 12 h, Fig. 3 ) is similar to the levels reported for synovial cells from paMononuclear Cell Modulation of Fibroblast Proliferationtients with rheumatoid arthritis (23) , cells that presumably are subject to in vivo activation. Furthermore, synovial cells were shown to increase PGE2 synthesis in response to a 10,000-20,000 mol wt factor released by mitogen-activated mononuclear cells (6) ; the increased PGE2 synthesis was accompanied by a mild suppression of proliferation. Human lymphoblastoid and human FB interferon, as well as the interferon inducer polyinosinate polycyctidylate [poly(l) poly(C)] have also been shown to stimulate PGE production by synovial FB (24) . Interferon suppressed FB proliferation in addition to stimulating PGE synthesis. Mononuclear cell SN could contain both interferon and interferon-inducing activity. Conversely, Wahl et al. (25) found that SN of guinea pig T lymphocytes stimulated both proliferation and PGE2 synthesis of isologous fibroblasts. No investigation was made of the role of the increased PGE2 synthesis in altering cell proliferation. Similarly, CTAP-I1I, a factor derived from an extract ofhuman platelets, has been shown to stimulate both FB PGE synthesis and FB proliferation (26, 27) . A growth-suppressive effect of PGE in these studies could have been masked by the presence of direct growth-stimulatory activity.
Prostaglandins can affect growth and function of FB in culture. Prostaglandin F2 has been shown to initiate cell proliferation in mouse FB (28) . Prostaglandins of the E series, conversely, have been shown to suppress cell proliferation (29) . The effect of prostaglandins on FB may depend not only on the type of prostaglandin, but also on the FB population employed, the state of endogenous prostaglandin and cAMP production, and the age ofthe culture (29, 30) . Thus, inhibitors ofprostaglandin synthesis were shown to have different effects on FB proliferation depending on the point in time when they were added to cultures (30) . Furthermore, even within an apparently homogeneous cell population there may be a heterogeneity of sensitivity to prostaglandin effects (29) . In our studies, prostaglandins of the E series were responsible for at least part of the growth suppression; production of iPGE by the FB was demonstrated, and addition of exogenous PGE2 duplicated the growth suppression. A contribution of prostaglandins other than PGE2 to the indomethacinreversible growth suppression cannot be excluded.
Prostaglandins may affect a diversity of cell functions in addition to cellular proliferation. In studies of rheumatoid synovial tissue, Dayer et al. (31, 32) found that PGE2 may modulate both collagen synthesis and the secretion of latent collagenase (32) by adherent rheumatoid synovial cells. The interferon-induced stimulation of synovial cell hyaluronic acid synthesis also appears to be mediated, in part, by PGE2 (33) . These effects may be secondary to PGE2-induced increases in cellular cAMP levels (34) .
The absorption of PBMC-SN activity by FB suggests the presence of a cell surface receptor for the PGEstimulatory product(s). The findings that PHA-induced lymphocyte proliferation was unaffected by PBMC-SN might be due to absence of such a receptor on lymphocytes, an explanation supported by the failure of these cells to absorb the PBMC-SN activity. It is possible, however, that continued release of new, active SN during the absorption incubation might obscure any loss of activity.
The induction of a prostaglandin-mediated autoregulatory phenomenon in FB by lymphocyte/monocyte products could be important in modulation of immune function. Several studies have indicated that prostaglandins may affect immunologically active cell populations. Adherent cells can suppress human T-cell mitogenesis by liberating prostaglandins (9) . Tumor cells have similarly been shown to suppress immune responsiveness by producing prostaglandins (35) . Macrophage response to endotoxin is mediated, at least partially, by prostaglandins: the endotoxin-stimulated synthesis of collagenase is dependent upon prostaglandin synthesis (36) . Exogenous PGE2 also stimulates macrophage collagenase production. Thus, fibroblasts can not only regulate their own growth by producing prostaglandins, as shown in the present study, but may also affect the activity of other cell types.
These (23, (37) (38) .
